(Q44116115)

29 November 2017

title

Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease (English)

1 reference

29 November 2017

0 references

Liming Hou

1

1 reference

29 November 2017

Inkyung Kang

series ordinal

2

1 reference

29 November 2017

Roger E Marchant

series ordinal

3

1 reference

29 November 2017

Michael G Zagorski

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

26 August 2002

1 reference

Journal of Biological Chemistry

29 November 2017

published in

1 reference

29 November 2017

volume

277

1 reference

29 November 2017

issue

43

1 reference

29 November 2017

page(s)

40173-40176

1 reference

Alzheimer's disease: genes, proteins, and therapy

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Protein oxidation in the brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Oxidation of methionyl residues in proteins: tools, targets, and reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Redox processes of methionine relevant to beta-amyloid oxidation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Methionine residues as endogenous antioxidants in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Solvent effects on self-assembly of beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Comparing the effect on protein stability of methionine oxidation versus mutagenesis: steps toward engineering oxidative resistance in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Metabolic regulation of brain Abeta by neprilysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

Thioflavine T interaction with amyloid β-sheet structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200338200

21 January 2018

Identifiers

DOI

10.1074/JBC.C200338200

1 reference

29 November 2017

1 reference